Annual EBIT
-$25.45 M
-$6.05 M-31.18%
December 31, 2023
Summary
- As of February 24, 2025, ANIK annual earnings before interest & taxes is -$25.45 million, with the most recent change of -$6.05 million (-31.18%) on December 31, 2023.
- During the last 3 years, ANIK annual EBIT has fallen by -$10.98 million (-75.90%).
- ANIK annual EBIT is now -141.42% below its all-time high of $61.45 million, reached on December 31, 2014.
Performance
ANIK EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$24.92 M
-$25.08 M-15575.78%
September 30, 2024
Summary
- As of February 24, 2025, ANIK quarterly earnings before interest & taxes is -$24.92 million, with the most recent change of -$25.08 million (-15575.78%) on September 30, 2024.
- Over the past year, ANIK quarterly EBIT has stayed the same.
- ANIK quarterly EBIT is now -204.38% below its all-time high of $23.87 million, reached on March 31, 2014.
Performance
ANIK Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$31.41 M
-$17.24 M-121.71%
September 30, 2024
Summary
- As of February 24, 2025, ANIK TTM earnings before interest & taxes is -$31.41 million, with the most recent change of -$17.24 million (-121.71%) on September 30, 2024.
- Over the past year, ANIK TTM EBIT has stayed the same.
- ANIK TTM EBIT is now -151.12% below its all-time high of $61.45 million, reached on December 31, 2014.
Performance
ANIK TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ANIK EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.2% | 0.0% | 0.0% |
| 3 y3 years | -75.9% | -1058.9% | -93.3% |
| 5 y5 years | -217.0% | -306.8% | -191.7% |
ANIK EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.7% | at low | <-9999.0% | at low | -121.7% | at low |
| 5 y | 5-year | -174.3% | at low | -618.9% | at low | -191.7% | at low |
| alltime | all time | -141.4% | at low | -204.4% | at low | -151.1% | at low |
Anika Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$24.92 M(<-9900.0%) | -$31.41 M(+121.7%) |
| Jun 2024 | - | $161.00 K(-103.2%) | -$14.17 M(-21.1%) |
| Mar 2024 | - | -$5.06 M(+218.2%) | -$17.96 M(-29.4%) |
| Dec 2023 | -$25.45 M(+31.2%) | -$1.59 M(-79.3%) | -$25.45 M(-16.6%) |
| Sep 2023 | - | -$7.67 M(+111.3%) | -$30.52 M(+6.5%) |
| Jun 2023 | - | -$3.63 M(-71.1%) | -$28.65 M(+0.9%) |
| Mar 2023 | - | -$12.55 M(+88.3%) | -$28.40 M(+46.4%) |
| Dec 2022 | -$19.40 M(+5.0%) | -$6.67 M(+15.0%) | -$19.40 M(-7.8%) |
| Sep 2022 | - | -$5.80 M(+71.5%) | -$21.03 M(+21.0%) |
| Jun 2022 | - | -$3.38 M(-4.9%) | -$17.38 M(-5.9%) |
| Mar 2022 | - | -$3.55 M(-57.2%) | -$18.47 M(-0.0%) |
| Dec 2021 | -$18.48 M(+27.7%) | -$8.30 M(+286.0%) | -$18.48 M(+13.7%) |
| Sep 2021 | - | -$2.15 M(-51.9%) | -$16.25 M(-9.1%) |
| Jun 2021 | - | -$4.47 M(+25.5%) | -$17.88 M(-4.6%) |
| Mar 2021 | - | -$3.56 M(-41.3%) | -$18.75 M(+29.6%) |
| Dec 2020 | -$14.47 M(-142.2%) | -$6.07 M(+60.6%) | -$14.47 M(+302.0%) |
| Sep 2020 | - | -$3.78 M(-29.3%) | -$3.60 M(-129.4%) |
| Jun 2020 | - | -$5.34 M(-845.8%) | $12.23 M(-58.5%) |
| Mar 2020 | - | $716.00 K(-85.1%) | $29.48 M(-13.9%) |
| Dec 2019 | $34.25 M(+57.5%) | $4.80 M(-60.1%) | $34.25 M(-12.7%) |
| Sep 2019 | - | $12.05 M(+1.1%) | $39.21 M(+9.7%) |
| Jun 2019 | - | $11.91 M(+117.3%) | $35.73 M(+1.9%) |
| Mar 2019 | - | $5.48 M(-43.8%) | $35.06 M(+61.2%) |
| Dec 2018 | $21.75 M(-52.4%) | $9.76 M(+13.9%) | $21.75 M(+0.2%) |
| Sep 2018 | - | $8.57 M(-23.8%) | $21.71 M(-7.2%) |
| Jun 2018 | - | $11.25 M(-243.6%) | $23.41 M(-21.7%) |
| Mar 2018 | - | -$7.83 M(-180.5%) | $29.89 M(-34.6%) |
| Dec 2017 | $45.73 M(-9.6%) | $9.73 M(-5.3%) | $45.73 M(-6.2%) |
| Sep 2017 | - | $10.27 M(-42.1%) | $48.74 M(-6.6%) |
| Jun 2017 | - | $17.73 M(+121.4%) | $52.16 M(+8.9%) |
| Mar 2017 | - | $8.01 M(-37.2%) | $47.90 M(-5.3%) |
| Dec 2016 | $50.61 M(+5.1%) | $12.74 M(-6.9%) | $50.61 M(-7.9%) |
| Sep 2016 | - | $13.69 M(+1.6%) | $54.93 M(+1.0%) |
| Jun 2016 | - | $13.47 M(+25.8%) | $54.38 M(+1.9%) |
| Mar 2016 | - | $10.71 M(-37.2%) | $53.34 M(+10.8%) |
| Dec 2015 | $48.13 M(-21.7%) | $17.07 M(+29.9%) | $48.13 M(+11.5%) |
| Sep 2015 | - | $13.13 M(+5.7%) | $43.16 M(+7.1%) |
| Jun 2015 | - | $12.43 M(+125.8%) | $40.31 M(-6.4%) |
| Mar 2015 | - | $5.50 M(-54.5%) | $43.08 M(-29.9%) |
| Dec 2014 | $61.45 M(+90.1%) | $12.09 M(+17.5%) | $61.45 M(+2.5%) |
| Sep 2014 | - | $10.29 M(-32.3%) | $59.95 M(+4.7%) |
| Jun 2014 | - | $15.20 M(-36.3%) | $57.23 M(+11.5%) |
| Mar 2014 | - | $23.87 M(+125.5%) | $51.31 M(+58.8%) |
| Dec 2013 | $32.32 M(+45.2%) | $10.59 M(+39.8%) | $32.32 M(+0.8%) |
| Sep 2013 | - | $7.57 M(-18.5%) | $32.06 M(+17.8%) |
| Jun 2013 | - | $9.29 M(+90.5%) | $27.22 M(+13.1%) |
| Mar 2013 | - | $4.88 M(-52.8%) | $24.07 M(+8.1%) |
| Dec 2012 | $22.25 M(+59.3%) | $10.33 M(+278.8%) | $22.25 M(+32.1%) |
| Sep 2012 | - | $2.73 M(-55.5%) | $16.84 M(-11.0%) |
| Jun 2012 | - | $6.13 M(+100.3%) | $18.93 M(+14.9%) |
| Mar 2012 | - | $3.06 M(-37.7%) | $16.47 M(+17.9%) |
| Dec 2011 | $13.97 M(+85.3%) | $4.92 M(+2.0%) | $13.97 M(+21.1%) |
| Sep 2011 | - | $4.82 M(+31.0%) | $11.53 M(+31.2%) |
| Jun 2011 | - | $3.68 M(+560.6%) | $8.79 M(+27.1%) |
| Mar 2011 | - | $556.70 K(-77.5%) | $6.92 M(-8.2%) |
| Dec 2010 | $7.54 M(+34.9%) | $2.48 M(+19.3%) | $7.54 M(+13.1%) |
| Sep 2010 | - | $2.08 M(+15.2%) | $6.66 M(+0.9%) |
| Jun 2010 | - | $1.80 M(+53.2%) | $6.60 M(+9.9%) |
| Mar 2010 | - | $1.18 M(-26.5%) | $6.01 M(+7.5%) |
| Dec 2009 | $5.59 M(+32.2%) | $1.60 M(-20.5%) | $5.59 M(+6.8%) |
| Sep 2009 | - | $2.02 M(+67.0%) | $5.23 M(+15.1%) |
| Jun 2009 | - | $1.21 M(+59.0%) | $4.55 M(+7.5%) |
| Mar 2009 | - | $759.40 K(-39.2%) | $4.23 M(+0.1%) |
| Dec 2008 | $4.23 M | $1.25 M(-6.2%) | $4.23 M(-17.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | $1.33 M(+49.5%) | $5.10 M(-9.7%) |
| Jun 2008 | - | $890.90 K(+17.9%) | $5.65 M(-7.7%) |
| Mar 2008 | - | $755.80 K(-64.4%) | $6.12 M(-7.1%) |
| Dec 2007 | $6.59 M(+21.4%) | $2.12 M(+12.8%) | $6.59 M(+23.4%) |
| Sep 2007 | - | $1.88 M(+37.9%) | $5.34 M(+3.2%) |
| Jun 2007 | - | $1.36 M(+11.5%) | $5.17 M(-7.8%) |
| Mar 2007 | - | $1.22 M(+40.5%) | $5.61 M(+3.4%) |
| Dec 2006 | $5.43 M(-36.5%) | $870.50 K(-49.3%) | $5.43 M(+0.2%) |
| Sep 2006 | - | $1.72 M(-4.7%) | $5.42 M(-28.9%) |
| Jun 2006 | - | $1.80 M(+73.2%) | $7.62 M(-2.1%) |
| Mar 2006 | - | $1.04 M(+21.1%) | $7.78 M(-9.0%) |
| Dec 2005 | $8.55 M(+33.9%) | $858.30 K(-78.1%) | $8.55 M(-15.1%) |
| Sep 2005 | - | $3.92 M(+99.3%) | $10.08 M(+31.4%) |
| Jun 2005 | - | $1.97 M(+8.9%) | $7.67 M(+9.7%) |
| Mar 2005 | - | $1.81 M(-24.2%) | $6.99 M(+9.4%) |
| Dec 2004 | $6.39 M(+973.5%) | $2.38 M(+57.7%) | $6.39 M(+32.0%) |
| Sep 2004 | - | $1.51 M(+17.3%) | $4.84 M(+30.1%) |
| Jun 2004 | - | $1.29 M(+6.9%) | $3.72 M(+61.0%) |
| Mar 2004 | - | $1.21 M(+44.5%) | $2.31 M(+288.1%) |
| Dec 2003 | $595.00 K(-118.2%) | $834.00 K(+113.3%) | $595.00 K(+9.8%) |
| Sep 2003 | - | $391.00 K(-423.1%) | $542.00 K(-166.3%) |
| Jun 2003 | - | -$121.00 K(-76.2%) | -$818.00 K(-57.3%) |
| Mar 2003 | - | -$509.00 K(-165.2%) | -$1.92 M(-41.5%) |
| Dec 2002 | -$3.27 M(-55.8%) | $781.00 K(-180.6%) | -$3.27 M(-28.7%) |
| Sep 2002 | - | -$969.00 K(-20.6%) | -$4.59 M(-9.1%) |
| Jun 2002 | - | -$1.22 M(-34.7%) | -$5.05 M(-24.5%) |
| Mar 2002 | - | -$1.87 M(+247.8%) | -$6.69 M(-7.0%) |
| Dec 2001 | -$7.41 M(+653.6%) | -$536.80 K(-62.4%) | -$7.19 M(+57.1%) |
| Sep 2001 | - | -$1.43 M(-50.1%) | -$4.58 M(-5.3%) |
| Jun 2001 | - | -$2.86 M(+20.7%) | -$4.83 M(+92.2%) |
| Mar 2001 | - | -$2.37 M(-214.1%) | -$2.51 M(+158.4%) |
| Dec 2000 | -$983.40 K(+4290.2%) | $2.07 M(-223.2%) | -$973.40 K(-68.3%) |
| Sep 2000 | - | -$1.68 M(+212.9%) | -$3.07 M(+93.6%) |
| Jun 2000 | - | -$538.30 K(-34.8%) | -$1.59 M(+42.3%) |
| Mar 2000 | - | -$825.30 K(+3584.4%) | -$1.11 M(+626.0%) |
| Dec 1999 | -$22.40 K(-100.9%) | -$22.40 K(-88.8%) | -$153.50 K(-40.5%) |
| Sep 1999 | - | -$200.00 K(+199.9%) | -$257.80 K(-175.3%) |
| Jun 1999 | - | -$66.70 K(-149.2%) | $342.20 K(-85.2%) |
| Mar 1999 | - | $135.60 K(-207.0%) | $2.31 M(-13.6%) |
| Dec 1998 | $2.57 M(-19.6%) | -$126.70 K(-131.7%) | $2.67 M(-53.9%) |
| Sep 1998 | - | $400.00 K(-78.9%) | $5.80 M(+11.5%) |
| Jun 1998 | - | $1.90 M(+280.0%) | $5.20 M(+40.5%) |
| Mar 1998 | - | $500.00 K(-83.3%) | $3.70 M(+8.8%) |
| Dec 1997 | $3.20 M(-218.5%) | $3.00 M(-1600.0%) | $3.40 M(-666.7%) |
| Sep 1997 | - | -$200.00 K(-150.0%) | -$600.00 K(-53.8%) |
| Jun 1997 | - | $400.00 K(+100.0%) | -$1.30 M(-45.8%) |
| Mar 1997 | - | $200.00 K(-120.0%) | -$2.40 M(-35.1%) |
| Dec 1996 | -$2.70 M(-10.0%) | - | - |
| Nov 1996 | - | -$1.00 M(+11.1%) | -$3.70 M(+15.6%) |
| Aug 1996 | - | -$900.00 K(+28.6%) | -$3.20 M(+3.2%) |
| Aug 1996 | -$3.00 M(+57.9%) | - | - |
| May 1996 | - | -$700.00 K(-36.4%) | -$3.10 M(+6.9%) |
| Feb 1996 | - | -$1.10 M(+120.0%) | -$2.90 M(+45.0%) |
| Nov 1995 | - | -$500.00 K(-37.5%) | -$2.00 M(0.0%) |
| Aug 1995 | -$1.90 M(+35.7%) | -$800.00 K(+60.0%) | -$2.00 M(+25.0%) |
| May 1995 | - | -$500.00 K(+150.0%) | -$1.60 M(-5.9%) |
| Feb 1995 | - | -$200.00 K(-60.0%) | -$1.70 M(0.0%) |
| Nov 1994 | - | -$500.00 K(+25.0%) | -$1.70 M(+21.4%) |
| Aug 1994 | -$1.40 M(-26.3%) | -$400.00 K(-33.3%) | -$1.40 M(-17.6%) |
| May 1994 | - | -$600.00 K(+200.0%) | -$1.70 M(+13.3%) |
| Feb 1994 | - | -$200.00 K(0.0%) | -$1.50 M(+15.4%) |
| Nov 1993 | - | -$200.00 K(-71.4%) | -$1.30 M(+18.2%) |
| Aug 1993 | -$1.90 M | -$700.00 K(+75.0%) | -$1.10 M(+175.0%) |
| May 1993 | - | -$400.00 K | -$400.00 K |
FAQ
- What is Anika Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Anika Therapeutics?
- What is Anika Therapeutics annual EBIT year-on-year change?
- What is Anika Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Anika Therapeutics?
- What is Anika Therapeutics quarterly EBIT year-on-year change?
- What is Anika Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Anika Therapeutics?
- What is Anika Therapeutics TTM EBIT year-on-year change?
What is Anika Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ANIK is -$25.45 M
What is the all time high annual EBIT for Anika Therapeutics?
Anika Therapeutics all-time high annual earnings before interest & taxes is $61.45 M
What is Anika Therapeutics annual EBIT year-on-year change?
Over the past year, ANIK annual earnings before interest & taxes has changed by -$6.05 M (-31.18%)
What is Anika Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ANIK is -$24.92 M
What is the all time high quarterly EBIT for Anika Therapeutics?
Anika Therapeutics all-time high quarterly earnings before interest & taxes is $23.87 M
What is Anika Therapeutics quarterly EBIT year-on-year change?
Over the past year, ANIK quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Anika Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ANIK is -$31.41 M
What is the all time high TTM EBIT for Anika Therapeutics?
Anika Therapeutics all-time high TTM earnings before interest & taxes is $61.45 M
What is Anika Therapeutics TTM EBIT year-on-year change?
Over the past year, ANIK TTM earnings before interest & taxes has changed by $0.00 (0.00%)